![]() |
Custom Search
|
In May 2007, FDA announced approval of Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of early Parkinson's Disease. On May 9, 2007, FDA announced the approval of Neupro (rotigotine transdermal system), a skin ... Read the entire article at Food & Drug Administration | ||||
|